The U.S. Food and Drug Administration (FDA) has approved a new medication for people with Alzheimer’s disease. Eli Lilly’s Kisunla (donanemab) is a once-monthly injection intended for adults ...
WASHINGTON (AP) — U.S. officials have approved another Alzheimer’sdrug that can modestly slow the disease, providing a new option for patients in the early stages of the incurable, memory ...
Some results have been hidden because they may be inaccessible to you